Study Shows Novel Probiotic Combination ‘AminoAlta’ Facilitates Plant Protein Absorption
PETALUMA, Calif., Oct. 6, 2020 /PRNewswire/ — SOFAR Americas, Inc., the U.S. subsidiary of SOFAR S.p.A. (Italy’s leading digestive health company, Milan metro-area) has announced the results and publication of a human study demonstrating, for the first time, a novel combination of two Lactobacillus paracasei strains, trade named ‘AminoAlta,’ which has been shown to increase the absorption of key amino acids in plant proteins. The presence of AminoAlta can provide a unique solution by helping to overcome the limitations of plant-based proteins, so that individuals can achieve better physical performance and general health.
For a variety of health, wellness, and ethical reasons, the plant-based food market is growing five (5) times faster than the general food market and is expected to reach $25 billion in sales by 2025. Whether consumers range from sedentary or active individuals to professional athletes, more consumers today want to get their protein from plant-based sources than ever before. As consumers become interested in plant-based foods, studies show that they prefer combining their proteins with probiotics rather than enzymes.
AminoAlta’s proprietary, patented blend has been scientifically shown to increase the body’s ability to absorb key amino acids from pea protein. The more amino acids your body can get from food, the more protein your body can create to build muscle, strengthen bones, support the immune system, and more. As athletes become increasingly interested in pivoting away from standard animal-based whey proteins to more healthful plant-based protein powders, they still want to consume a product that allows for maximum fitness result. The AminoAlta probiotic strain assists in the hard work of freeing amino acids from their protein structure, making them more available for the body to absorb, and possibly in a comparable and healthier manner, as compared to …